Direct Demonstration of Separate Receptors for Growth and Metabolic Activities of Insulin and Multiplication-stimulating Activity (an Insulinlike Growth Factor) Using Antibodies to the Insulin Receptor
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Insulin and such insulinlike growth factors as multiplication stimulating activity (MSA) are related polypeptides that have common biological activities. Both insulin and MSA produce acute metabolic responses (stimulation of glucose oxidation in isolated fat cells) as well as growth effects (stimulation of [(3)H]thymidine incorporation into DNA in cultured fibroblasts). In addition, most cells have separate receptors for insulin and insulinlike growth factors, and both peptides have weaker affinity for each other's specific receptors than for their own. To determine, therefore, whether these effects are mediated by receptors for insulin, insulinlike growth factors, or both, we have selectively blocked insulin receptors with a specific antagonist, namely Fab fragments derived from naturally occurring antibodies to the insulin receptor. In rat adipocytes, 10 mug/ml of antireceptor Fab inhibited insulin binding by 90%, whereas it inhibited MSA binding <5%. The anti-insulin receptor Fab is without intrinsic biological activity, but acts as a competitive inhibitor of insulin receptors. Blockade of insulin receptors with Fab fragments produced a 30-fold rightward shift in the dose response for stimulation of glucose oxidation by both insulin and MSA. The dose-response curves for stimulation of oxidation by vitamin K(5) and spermine, agents that stimulate glucose oxidation through noninsulin receptor pathways, were not affected by the blockade of insulin receptors with Fab antibody fragments. These data suggest that this acute metabolic effect of both insulin and MSA is mediated via the insulin receptor. In cultured human fibroblasts, 10 mug/ml of Fab inhibited insulin binding by 90% and MSA binding by 15%. In fibroblasts, however, blockade of the insulin receptor did not alter the dose response for stimulation of thymidine incorporation into DNA by either insulin or MSA. Furthermore, intact antireceptor antibody immunoglobulin (Ig)G, which produces multiple other insulinlike effects, and Fab fragments of antireceptor antibody did not stimulate thymidine incorporation. These data demonstrate directly that the insulin receptor mediates the metabolic effects of insulin and MSA, whereas the growth-promoting action of both peptides is mediated by the MSA receptor or other growth factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Metabolism of Isolated Fat Cells
Rodbell, M. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51687-2 · Cited by 4,427
Rinderknecht, E., & Humbel, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.
Rodbell, M. (1964) · PubMed · Cited by 1,387
The Syndromes of Insulin Resistance and Acanthosis Nigricans: Insulin-Receptor Disorders in Man
Kahn, C. R., Flier, J. S., Bar, R. S., Archer, J. A., Gorden, P., Martin, M. M., & Roth, J. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941401 · Cited by 1,106
Self-citationPrimary structure of human insulin‐like growth factor II
Rinderknecht, E., & Humbel, R. E. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80237-3 · Cited by 780
Hjelm, H., Hjelm, K., & Sjöquist, J. (1972) · FEBS Letters · doi:10.1016/0014-5793(72)80680-x · Cited by 612
Flier, J. S., Kahn, C. R., Roth, J., & Bar, R. S. (1975) · Science · doi:10.1126/science.170678 · Cited by 438
Self-citationInsulin Interactions with Liver Plasma Membranes
Freychet, P., Kahn, R., Roth, J., & Neville, D. M. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45126-0 · Cited by 397
Direct demonstration that receptor crosslinking or aggregation is important in insulin action
Kahn, C. R., Baird, K. L., Jarrett, D. B., & Flier, J. S. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4209 · Cited by 389
Self-citationZAPF, J., SCHOENLE, E., & FROESCH, E. R. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12377.x · Cited by 378
Binding and degradation of 125I-labelled insulin by isolated rat fat cells
Gammeltoft, S., & Gliemann, J. (1973) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(73)90161-x · Cited by 334
Zapf, J., Rinderknecht, E., Humbel, R. E., & Froesch, E. R. (1978) · Metabolism · doi:10.1016/0026-0495(78)90267-6 · Cited by 248
Effects of Autoantibodies to the Insulin Receptor on Isolated Adipocytes
Kahn, C. R., Baird, K., Flier, J. S., & Jarrett, D. B. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108861 · Cited by 242
Self-citationFlier, J. S., Kahn, C. R., Jarrett, D. B., & Roth, J. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108600 · Cited by 207
Self-citationIdentification of a Receptor for Somatomedin-Like Polypeptides in Human Fibroblasts*
Rechler, M. M., Nissley, S. P., Podskalny, J. M., et al. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-5-820 · Cited by 107
Self-citationThe Somatomedins and Their Actions
Wyk, J. J. V., & Underwood, L. E. (1978) · Biochemical Actions of Hormones · doi:10.1016/b978-0-12-452805-5.50009-0 · Cited by 106
Nonsuppressible insulin-like activity in human serum
Jakob, A., Hauri, C., & Froesch, E. R. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105951 · Cited by 98
Lockwood, D. H., & East, L. E. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42026-7 · Cited by 85
Insulin-receptor antibodies mimic a late insulin effect
OBBERGHEN, E. V., Spooner, P. M., Kahn, C. R., Chernick, S. S., GARRISON, M. M., Karlsson, F. A., & Grünfeld, C. (1979) · Nature · doi:10.1038/280500a0 · Cited by 78
Self-citationHuman Somatomedin, the Growth Hormone-Dependent Sulfation Factor, Is Anti-Lipolytic
Underwood, L. E., Hintz, R. L., Voina, S. J., & Wyk, J. J. V. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-2-194 · Cited by 52
Studies of glucose transport system of fat cells: effects of insulin and insulin mimickers.
Livingston, J. N., Amatruda, J. M., & Lockwood, D. H. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.234.5.e484 · Cited by 20
Cited by
Insulin‐like growth factors I and II
HUMBEL, R. E. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15595.x · Cited by 999
The Nature and Regulation of the Receptors for Insulin-Like Growth Factors
Rechler, M. M., & Nissley, S. P. (1985) · Annual Review of Physiology · doi:10.1146/annurev.ph.47.030185.002233 · Cited by 638
Self-citationReceptor-Mediated Transport of Insulin Across Endothelial Cells
King, G. L., & Johnson, S. M. (1985) · Science · doi:10.1126/science.3883490 · Cited by 471
Self-citationKing, G. L., Goodman, A. D., Buzney, S., Moses, A., & Kahn, C. R. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111764 · Cited by 437
Self-citationHuman adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.
White, R. T., Damm, D., Hancock, N., Rosen, B. S., Lowell, B. B., Usher, P., Flier, J. S., & Spiegelman, B. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50409-4 · Cited by 408
Metadata
- Authors
- King, G. L., Kahn, C. R., Rechler, M. M., & Nissley, S. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-07-01
- Volume
- 66
- Issue
- 1
- Pages
- 130-140
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2029772086
- Cited by
- 344
- References
- 22
- FWCI
- 26.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.